Terms: = Lung cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Treatment
12 results:
1. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
3. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
4. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Follow-Up Surveillance After Curative-Intent treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis.
Stirling RG; Chau C; Shareh A; Zalcberg J; Fischer BM
J Thorac Oncol; 2021 May; 16(5):784-797. PubMed ID: 33588110
[TBL] [Abstract] [Full Text] [Related]
6. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
Bi Y; Jiang Y; Li X; Hou G; Li K
J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
[TBL] [Abstract] [Full Text] [Related]
7. Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Pavel ME; Singh S; Strosberg JR; Bubuteishvili-Pacaud L; Degtyarev E; Neary MP; Carnaghi C; Tomasek J; Wolin E; Raderer M; Lahner H; Valle JW; Pommier R; Van Cutsem E; Tesselaar MET; Fave GD; Buzzoni R; Hunger M; Eriksson J; Cella D; Ricci JF; Fazio N; Kulke MH; Yao JC
Lancet Oncol; 2017 Oct; 18(10):1411-1422. PubMed ID: 28838862
[TBL] [Abstract] [Full Text] [Related]
8. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract] [Full Text] [Related]
9. Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma.
Li K; Pan X; Bi Y; Xu W; Chen C; Gao H; Shi B; Jiang H; Yang S; Jiang L; Li Z
Oncotarget; 2016 Jan; 7(3):2496-507. PubMed ID: 26684028
[TBL] [Abstract] [Full Text] [Related]
10. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract] [Full Text] [Related]
11. [lung cancer in Germany - the current state of management].
Blum T; Schönfeld N; Kollmeier J; Ammenwerth W; Grüning W; Nehls W; Bauer TT
Pneumologie; 2011 Jan; 65(1):7-18. PubMed ID: 20848379
[TBL] [Abstract] [Full Text] [Related]
12. The heparan sulfate proteoglycan gpc3 is a potential lung tumor suppressor.
Kim H; Xu GL; Borczuk AC; Busch S; Filmus J; Capurro M; Brody JS; Lange J; D'Armiento JM; Rothman PB; Powell CA
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):694-701. PubMed ID: 12816733
[TBL] [Abstract] [Full Text] [Related]
